Navigation Links
BD to Present at the 29th Annual J. P. Morgan Healthcare Conference
Date:1/4/2011

FRANKLIN LAKES, N.J., Jan. 4, 2011 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the 29th Annual J. P. Morgan Healthcare Conference on Monday, January 10, 2011, at 6:00 p.m. (ET).

A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Monday, January 17, 2011.  

About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com. Contact:Zachary A. Nagle, Investor Relations – 201-847-5453Colleen T. White, Corporate Communications – 201-847-5369
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Trinity Biotech plc to Present at Sidoti & Companys Micro-Cap Conference on January 10, 2011
2. ERT to Present at the 29th Annual J.P. Morgan Healthcare Conference on January 13, 2011
3. Endo to Present at the J.P. Morgan 29th Annual Healthcare Conference
4. Warner Chilcott to Present at the 29th Annual J.P. Morgan Healthcare Conference
5. NxStage to Present at the 29th Annual J.P. Morgan Healthcare Conference
6. ADVENTRX Pharmaceuticals to Present at the 4TH Annual OneMedForum Business Development and Investment Conference on January 11
7. Syndax Pharmaceuticals to Present at Biotech Showcase 2011
8. PAREXEL International to Present at J.P. Morgan Healthcare Conference
9. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
10. Medco CEO to Present at Upcoming Healthcare Conferences
11. Misonix to Present at Sidoti & Company 2011 Micro Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... FRANCISCO, Calif. , Aug. 3, 2015 /PRNewswire/ ... the treatment of cancer, today announced the promotion ... Debanjan Ray , who previously served ... management, has been promoted to senior vice president ... CytomX, Mr. Ray held positions as the vice ...
(Date:8/3/2015)... OSAKA, Japan and FLORHAM PARK, ... today announced that once-daily naldemedine met its primary and ... for the treatment of opioid-induced constipation (OIC) in adult ... oral, peripherally acting mu-opioid receptor antagonist (PAMORA). This is ... its primary and key secondary endpoints. Study ...
(Date:8/3/2015)... Inc. (PK:ECIA), a medical device company owning patented surgical ... invasive surgery, today announced financial results for its fiscal ... The Company posted quarterly net revenue of $2.454 ... or $(0.02) per share. These results compare to net ... $202 thousand, or $(0.02) per share, in the year-ago ...
Breaking Medicine Technology:CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Naldemedine Meets Primary Endpoint In Phase 3 Study For The Treatment Of Opioid-Induced Constipation 4Encision Reports First Quarter Fiscal Year 2016 Results 2Encision Reports First Quarter Fiscal Year 2016 Results 3Encision Reports First Quarter Fiscal Year 2016 Results 4Encision Reports First Quarter Fiscal Year 2016 Results 5
... , ST. LOUIS , Feb. 8 ... its first Stereotaxis Magnetic Navigation System in Taiwan at ... a Grand Opening event on January 26 that received ... been successfully performed using Stereotaxis at the hospital. , "All too ...
... Md. , Feb. 8 Novavax, Inc. (Nasdaq: ... to discontinue negotiations in its pursuit of the previously announced ... Novavax,s virus-like-particle (VLP)-based vaccines against influenza in the country of ... inability to agree on acceptable terms of the proposed collaboration ...
Cached Medicine Technology:Stereotaxis Installs First System in Taiwan 2Stereotaxis Installs First System in Taiwan 3Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration 2Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration 3Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration 4
(Date:8/3/2015)... ... August 03, 2015 , ... Hub International Insurance ... Williams has joined its growing California employee benefits division. Mr. Williams will ... his clients. Mr. Williams will be joining the newly integrated Northern California employee ...
(Date:8/3/2015)... ... August 03, 2015 , ... Foot and Ankle Specialists of ... podiatrist, creating the largest medical practice in the Mid-Atlantic region – and the second ... 21 locations with 33 doctors. , Dr. Hetal Kathrotiya-Mago is a Maryland native. She ...
(Date:8/3/2015)... ... ... Did you know that there are thousands of Seniors or Elderly ... options which A-1 Home Care Agency specialize in? In fact, diversity, multi-cultural, financing options, ... Care Agency is known for. , With all the Los Angeles ...
(Date:8/2/2015)... Ky. (PRWEB) , ... August 03, 2015 , ... A ... recurrence of some childhood cancers. The study is led by Kenneth G. Lucas, ... the University of Louisville in collaboration with colleagues at Kosair Children’s Hospital ...
(Date:8/2/2015)... Raleigh, NC (PRWEB) , ... August 02, 2015 , ... ... be a powerful prognostic indicator for mesothelioma. Surviving Mesothelioma has just posted an article ... at the University of New South Wales tested for Ki67 expression in tissue samples ...
Breaking Medicine News(10 mins):Health News:HUB International Insurance Services Announces Joe Williams Has Joined its Northern California Employee Benefits Division 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 2Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 3Health News:Leading Foot and Ankle Medical Practice Adds Three New Podiatrists 4Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 2Health News:A-1 Home Care in Los Angeles and Orange County Honors Exceptional Office Staff 3Health News:UofL Physicians Conducting Vaccine Trial for Children with Relapsed Tumors at Kosair Children’s Hospital 2Health News:Scientists Link Protein Marker with Mesothelioma Prognosis in New Study, According to Surviving Mesothelioma 2
... to be hurt from physical injuries such as a fall or ... ,The University of Queensland study found any alcohol consumption quadrupled ... alcohol and this risk remained at 2.5 times that of a ... and specific drinks such as beer or spirits did not increase ...
... a threefold risk of premature death, according to a new ... Internal Medicine.// , Lead researcher, Dr. Frank B. ... Harvard School of Public Health says, “This study underscores the ... for children, but increases the risk for death in adulthood." ...
... health lecturers Mary Seddon and Alan Merry there is ... were victims of preventable medical errors. ,The ... Journal mainly focused on how careless attitudes of the ... suffering adverse events. Statistics show that more than 1500 ...
... health alert after 15 people died of Japanese encephalitis ... in the past two weeks, officials said.// ,An ... epidemic proportions in the four districts of Jorhat, Dibrugarh, ... hit by the disease. ,"We have ...
... absence of an AIDS policy action, the potential economic cost ... Development Programme (UNDP) report.// ,"The potential costs to the ... HIV epidemic could be quite high," according to the report ... the National Council of Applied Economic Research (NCAER) with the ...
... children does not merit the prescription of antibiotics, researchers ... if the child's condition worsens. Antibiotics are known to ... every small pretext, has led to the rise of ... defeat even the most potent antibiotics. When researchers prescribed ...
Cached Medicine News:Health News:Alcohol Drinkers Prone to Physical Injuries 2Health News:Risk Of Premature Death In Obese Adolescents 2Health News:Risk Of Premature Death In Obese Adolescents 3Health News:HIV Epidemic Can Slow Down Economic Growth: UNDP 2
... monitor offers a comprehensive array of features ... pediatric and neonate patients, to magnetic resonance ... is the first MR monitor designed to ... neonate patient monitoring. The new monitor is ...
... specific antigen (PSA) is a serine protease that ... epithelial cells of the acini and ducts. Normal ... 0.1-2.6 ng/mL. Reports have suggested that elevated level ... must useful tumor markers in diagnosis of prostate ...
... in vitro assay for detection of alpha ... is a protein with molecular mass ranging ... concentration in serum is below 9 ng/mL; ... ovarian, testicular and presacral teratocarcinomas, and other ...
The IDS Gamma-B 25-Hydroxy Vitamin D kit is a conventional liquid phase radioimmunoassay intended for the quantitative determination of 25-hydroxy vitamin D (25-OHD) and other hydroxylated metabolite...
Medicine Products: